Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 27/09/20111 min de lecture
Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products; Availability
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "User Fee Waivers, Reductions, and Refunds for Drug and Biological Products." This guidance provides recommendations to applicants considering whether to request a waiver or reduction in user fees. This guidance is a revision of the draft guidance entitled "Draft Interim Guidance Document for Waivers of and Reductions in User Fees," issued July 16, 1993.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →